Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

COVID-19 can worsen upper gastrointestinal bleeding, requiring quick and varied treatments.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Higher doses of isotretinoin may lead to more hair loss.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Retinoids are effective for severe acne and psoriasis but can cause serious side effects and birth defects.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

Laser treatment for lipomas improves quality of life with quick recovery and high satisfaction.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Essential oils may improve dogs' health and melatonin can help with their sleep and anxiety, but both should be used carefully.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.